Daily Top 50 Gainers & Losers

Market Regime — the colored bar under each day is the market's overall “weather,” scored from the indexes (trend, fear/VIX, small-cap breadth). It's market-wide context, not a stock pick: even a great company gets dragged down in a red tape. Read it to gauge when to lean in vs. wait for calmer water — click any day for the full read.

Risk-On · supportive Neutral Risk-Off · headwind Stress · fear

Market Recap · Monday, September 28, 2026

Snapshot: Sep 28, 2026 · 5:00 PM 100 stocks analyzed

Strong Down Day

Mon, Sep 28, 2026 Broad Selloff High

Broad selloff with S&P and Russell 2000 both down ~1%, though high dispersion and healthcare strength among gainers showed pockets of resilience in a risk-off day.

60% Markets suffered a broad-based selloff across all major indices, with the S&P 500 down 1.04%, Russell 2000 hit hardest at -1.98%, and VIX spiking 13% to signal renewed fear; Healthcare dominated losers with 27% of decliners while also capturing 33% of gainers, revealing sharp internal rotation within the sector.
25% High dispersion characterized the day as 50 stocks surged an average 20.3% while 50 crashed an average -29.5%, led by outlier gainers like SOAR (+68.7% on $1.2B AI infrastructure order) and LFCR (+55.5% on acquisition), offset by extreme losers like XHLD (-92.4%) and NCI (-84.2%) with no clear catalysts disclosed.
15% Getty Images collapsed 40.6% after Bloomberg reported confidential DIP financing talks signaling distress, while MongoDB fell 18.5% on CEO departure to Meta, and MediciNova plunged 19.8% on missed Phase 2 endpoints, demonstrating that company-specific bad news amplified the broader selloff in select names.

Healthcare drove 33% of gainers YDES on a 5-day gainers streak 5 names returned after long absences YDES · 5-day gainers streak GENVR · 5-day losers streak LFCR — first appearance

Market Regime

Mon, Sep 28, 2026 Neutral conf: medium macro · prototype

-3

Neutral −100 … +100 · + tailwind / − headwind

VIX16.1 p43 Drawdown-1.5% Held4d · building SinceSep 23

Top drivers: Small-cap leadership ▼ S&P drawdown (60d) ▲ VIX percentile ▲

processId: history-market-regime

Market Indexes

Mon, Sep 28, 2026 13

S&P 500

7,683.69

−81.01

-1.04%

Dow Jones

51,481.51

−567.32

-1.09%

NASDAQ Composite

26,820.38

−301.71

-1.11%

NASDAQ 100

30,276.81

−205.54

-0.67%

DJ US Total Market

75,700.10

−864.82

-1.13%

Russell 1000

4,173.41

−47.72

-1.13%

S&P MidCap 400

3,622.00

−42.45

-1.16%

Russell 2000

2,817.91

−57.45

-2.00%

Russell 2500

1,208.06

−10.33

-0.85%

Russell 3000

4,346.34

−51.24

-1.17%

Nasdaq Financial-100

7,342.52

−79.04

-1.07%

NIFTY 50

22,780.25

−548.75

-2.35%

VIX

16.07

+1.86

+13.09%

Biggest Gainers

Mon, Sep 28, 2026 50

SOAR

Volato Group, Inc.Industrials

$0.32+$0.12

+68.7%

NYSE · Mkt cap $7.8 M

Volato Group's Alignment Engine subsidiary announced $1.2 billion in four-year AI infrastructure orders from a major customer, triggering a 68.71% surge as the market repriced the stock on material new revenue visibility.

The headline establishes that Volato's Alignment Engine subsidiary secured two take-or-pay orders totaling $1.2 billion over four years with a large AI customer. This is a concrete, material contract announcement with defined duration and payment certainty (take-or-pay language means the customer must pay regardless of usage). For a micro-cap stock trading at $0.32, the announcement of $1.2 billion in committed revenue represents substantial earnings visibility and removes execution risk around revenue generation. The timing of the announcement on the same day as the price move strongly suggests this is the direct cause. Take-or-pay contracts are particularly valuable to investors because they reduce downside risk and provide predictable cash flow. The market's 68% response reflects both the magnitude of the order relative to the company's likely current revenue base and the quality of certainty the contract structure provides.

EGG

Enigmatig LimitedIndustrials

$4.21+$1.55

+55.6%

NYSE · Mkt cap $87 M

No news headlines were found in the last 48 hours for EGG, so the 55.56% single-day surge likely stems from a technical catalyst, delayed news, or market rumor not yet captured in the provided feed.

The absence of recent headlines makes pinpointing the cause difficult. A stock moving into the top two gainers of the day with no simultaneous news coverage suggests either a delayed dissemination lag between the market move and news indexing, a technical catalyst such as short covering or options expiry effects, or a company-specific announcement (earnings, clinical trial results, financing, management change) that has not yet appeared in the Yahoo Finance RSS feed used here. Small-cap stocks like EGG are more prone to outsized moves on limited volume and can be driven by insider activity, analyst upgrades, or market sentiment shifts that precede formal announcements.

LFCR

Lifecore Biomedical, Inc.

$6.53+$2.33

+55.5%

ARAY

Accuray IncHealthcare

$0.30+$0.08

+37.5%

NASDAQ · Mkt cap $35 M

Accuray announced a partnership with Samsung NeuroLogica on advanced volumetric imaging for its CyberKnife platform, which likely drove the 37% single-day gain as investors responded to the strategic collaboration and technology expansion news.

On September 28, Accuray announced agreements with Samsung NeuroLogica to integrate mobile CT imaging capabilities with its CyberKnife precision radiotherapy system. This represents a substantive product development milestone combining Samsung's volumetric imaging expertise with Accuray's treatment delivery platform. The timing of the announcement (morning of September 28) aligns precisely with the stock's 37% rally that same day, suggesting direct market response. For a micro-cap stock trading at $0.30, such partnerships can be viewed as significant validation and a potential revenue or product roadmap catalyst. The collaboration addresses a real clinical need—improved anatomical visualization during radiotherapy—which could enhance the competitive position of Accuray's CyberKnife system. No contradictory news or negative earnings/guidance was present in the provided headlines.

UYSCR

UY Scuti Acquisition Corp.

$0.11+$0.03

+37.4%

KNDI

Kandi Technologies Group Inc

$0.79+$0.23

+36.8%

ABLV

Able View Global Inc. - Class B Ordinary SharesConsumer Cyclical

$1.65+$0.41

+33.1%

NASDAQ · Mkt cap $41 M

No news headlines were found in the last 48 hours for ABLV, so the 33% gain likely stems from technical trading, short covering, or an announcement not yet captured in the RSS feed.

The absence of recent headlines makes it impossible to pinpoint a specific catalyst. ABLV is a micro-cap stock trading at $1.65, which typically exhibits high volatility and can be susceptible to technical moves, retail interest, or short squeezes when volume spikes. Stocks in this price range often move sharply on minimal volume shifts or delayed news dissemination. The move could reflect a company announcement, earnings release, or strategic development that has not yet appeared in major financial news feeds, or it could be driven by technical chart action such as a break above resistance, options expiry effects, or covering of short positions. Without access to the actual event triggering the move, attribution remains speculative.

SLXN

Biomotion SciencesHealthcare

$0.25+$0.08

+33.1%

NASDAQ · Mkt cap $540 K

Silexion Therapeutics announced positive preclinical findings for SIL204 demonstrating a novel mechanism for drug delivery in KRAS-driven cancers, likely driving the 33% intraday gain in this early-stage biotech stock.

The company released preclinical research showing that SIL204 can leverage native serum lipids to achieve intracellular delivery and effective KRAS oncogene knockdown. For a micro-cap biotech stock trading at $0.25, positive mechanistic validation from translational research can trigger substantial single-day rallies, particularly if the findings suggest a viable pathway to clinical development. The announcement addresses a key technical hurdle in KRAS-targeted therapeutics, which represents a significant market opportunity. However, preclinical findings carry inherent uncertainty regarding clinical translation, efficacy, safety, and regulatory approval risk. The stock's micro-cap status and penny-stock price point mean moves of this magnitude can also reflect thin liquidity and retail investor enthusiasm rather than proportional fundamental revaluation alone.

MEDS

Trxade Group IncHealthcare

$3.81+$0.90

+29.2%

NASDAQ · Mkt cap $4.4 M

DataMeds AI (MEDS) surged 29% on the launch of its "Health Lives Here" mobile app in partnership with Tollo Health, combining GLP-1 telehealth, pharmacy services, and health tracking capabilities announced today.

The stock's sharp intraday jump directly aligns with the announcement of a new integrated healthcare platform launching on September 28, 2026. The company's strategic move into the high-growth GLP-1 telehealth sector, combined with partnerships (Tollo Health and NFL Alumni Health for awareness), appears to have excited investors who may view this as a meaningful revenue diversification or growth driver. The timing of multiple press releases on the same day amplified visibility. The market reaction suggests investors believe this app launch represents a tangible product milestone and opens access to the booming GLP-1 weight-loss and diabetes-management market. However, the headlines do not provide financial projections, revenue guidance, user adoption targets, or competitive positioning details that would fully justify or contextualize the magnitude of the move.

RDACR

Rising Dragon Acquisition Corp. Rights

$0.10+$0.02

+28.8%

NASDAQ

No news headlines were found in the last 48 hours, so the 28.75% gain in this SPAC rights unit is likely driven by either technical trading activity, warrant redemption mechanics, or a delayed market reaction to an older announcement not captured in the recent feed.

Rising Dragon Acquisition Corp. Rights (RDACR) is a microcap SPAC-related security trading at $0.10, a price point typical for rights offerings or post-merger warrant activity. The absence of any news in the 48-hour window preceding the jump suggests the catalyst was not a fresh corporate announcement. For SPAC-related instruments, moves of this magnitude can stem from several sources: redemption pressure or deadline events tied to the underlying SPAC's business combination timeline, algorithmic accumulation in thinly traded securities, or delayed coverage of developments announced more than 48 hours prior. The low absolute price and small float typical of rights offerings can amplify percentage moves on modest volume. Without corroborating news, attributing the move to a specific event is not possible.

SMJF

SMJ International Holdings Inc.Consumer Cyclical

$2.17+$0.44

+27.6%

NYSE · Mkt cap $297 M

No headlines were found in the last 48 hours, so the cause of the 27.62% gain is unclear. The jump may reflect delayed news, technical trading, or market speculation unrelated to recent public announcements.

The absence of any news headlines in the 48 hours preceding this significant intraday gain makes it impossible to attribute the move to a specific corporate event or market development. SMJF, a micro-cap international holdings company, lacks the visibility that typically generates immediate news coverage, which complicates root-cause analysis. Stocks in this category sometimes experience sharp moves on low volume due to technical factors such as options expiration, short covering, or algorithmic rebalancing. Alternatively, the catalyst could be information disseminated through channels not captured by Yahoo Finance's RSS feed, such as social media coordination, paid research notes, or corporate announcements made through less prominent venues. Without access to intraday volume data, order flow, or corroborating reporting, the specific driver remains speculative.

WBUY

WEBUY GLOBAL LTD. - Ordinary SharesConsumer Cyclical

$0.91+$0.20

+24.8%

NASDAQ · Mkt cap $4.2 M

WEBUY GLOBAL reported a 94.4% jump in first-half 2026 revenue to $14.3 million with gross profit surging 132% and net losses narrowing 57%, driven by a strategic shift from grocery to travel operations, directly triggering the 24.81% stock rally.

The company released earnings results on September 28 showing strong operational momentum across multiple metrics. Revenue nearly doubled year-over-year from continuing operations, gross profit more than doubled, and the net loss position improved significantly by 57%. The headlines specifically attribute this performance to a strategic business pivot from grocery operations toward travel services, which appears to have expanded margins substantially. For a micro-cap stock trading near $0.91, a beat on this scale with positive margin expansion and loss narrowing represents material fundamental improvement. The timing of the announcement during market hours on the same day as the stock jump, combined with the magnitude of the gains reported, strongly suggests the earnings release drove the move.

YDES

YD BIO LIMITEDHealthcare

$7.11+$1.41

+24.6%

NASDAQ · Mkt cap $317 M

No news headlines were published in the last 48 hours for YDES, so the 24.63% intraday jump cannot be attributed to a confirmed company announcement or market event based on available evidence.

The absence of recent news headlines makes it impossible to identify a specific catalyst for the 24.63% gain. YD Bio is a biotech company, and stocks in this sector can move sharply on multiple types of events: clinical trial results or announcements, regulatory decisions, partnership deals, insider buying, or short covering. The magnitude of the single-day move suggests either material company news that has not yet been indexed into financial news feeds, technical or algorithmic trading activity, or possibly rumors circulating on social platforms or trading forums that preceded formal news releases. Without confirmed information, any explanation remains speculative.

SLBT

SL Science Holding LimitedHealthcare

$1.91+$0.36

+22.8%

NASDAQ · Mkt cap $1.8 B

No news headlines were found in the last 48 hours, so the 22.83% gain likely reflects technical trading activity, delayed market reaction to an earlier announcement, or other non-headline catalyst not captured in the available data.

The absence of any Yahoo Finance headlines in the 48-hour window prior to this snapshot is the key constraint. SLBT (SL Science Holding Limited) is a smaller-cap NASDAQ-listed company, and such stocks can experience sharp intraday or daily swings driven by several mechanisms: a delayed market reaction to a press release issued outside the headline capture window, short-covering or technical bounce from oversold conditions, sector rotation flows, insider trading activity being absorbed by the market, or rumors circulating on social media or forums that don't generate formal news coverage. Without visibility into earnings reports, clinical trial results, partnership announcements, or regulatory filings released more than 48 hours ago, we cannot definitively link the move to a specific event. The rank as the 14th biggest gainer suggests broad retail or momentum interest, but causation remains unclear.

PGSS

Pegasus Digital Mobility Acquisition Corp.

$4.37+$0.75

+20.7%

ZSQR

Z Squared Inc.Technology

$4.55+$0.77

+20.4%

NASDAQ · Mkt cap $218 M

No news headlines were published about ZSQR in the last 48 hours, so the 20.37% gain likely reflects a delayed market reaction to an earlier event, technical trading, or undisclosed developments.

The absence of recent news coverage for a stock posting a top-20 daily gain suggests either that the catalyst preceded the 48-hour window by hours or days and the market is only now responding, or that the move reflects technical factors such as short covering, options expiration mechanics, or algorithmic trading. For a micro-cap NASDAQ name like ZSQR, catalyst categories that typically drive outsized single-day moves include clinical trial results, regulatory approvals, restructuring announcements, insider transactions, or shifts in funding status. Without access to headlines or specific company fundamentals, we cannot isolate which mechanism is at play. The stock's mid-tier rank among daily gainers suggests this is a material move but not an extreme outlier, which is consistent with delayed news absorption or technical mean-reversion rather than a shock event.

BYSI

Beyondspring IncHealthcare

$1.12+$0.15

+19.6%

NASDAQ · Mkt cap $30 M

No headlines found in the last 48 hours to explain the 19.57% intraday gain, suggesting the move may be driven by technical factors, delayed news coverage, or market rumors rather than a disclosed corporate event.

The absence of any news headlines in the last 48 hours is noteworthy for a stock ranking in the top 20 gainers of the day. Beyondspring is a small-cap biopharmaceutical company, and such stocks are often sensitive to clinical trial developments, regulatory decisions, partnership announcements, or insider activity that may circulate through market channels before formal press release pickup. The 19.57% move could reflect a short squeeze on a thinly traded micro-cap, positive clinical data released through non-traditional channels, sector rotation into biotech, or simply algorithmic or retail clustering around momentum. Without confirmatory news headlines, the specific catalyst remains unknown, though biotech volatility and technical factors are reasonable starting hypotheses for this company profile.

CANG

Cango Inc-KYFinancial Services

$2.29+$0.37

+19.0%

NYSE · Mkt cap $69 M

Jones Trading initiated coverage of Cango with a Buy rating and $4.00 price target on September 28, directly triggering the 19% surge in CANG stock during Monday trading.

The headline explicitly establishes that Wall Street firm Jones Trading launched coverage on Cango Inc with a Buy rating and a $4.00 price target, which represents a 75% upside from the reported $2.29 closing price. The timing alignment is clean: the coverage announcement coincides precisely with the intraday surge described as over 20% on the same date. For a small-cap stock like Cango, initiation of coverage by a Wall Street firm with a bullish thesis and specific price target can catalyze meaningful share price movement, particularly if it attracts fresh institutional or retail attention. The news headline references bullish commentary but does not provide detail on the specific investment rationale, though the substantial price target implies conviction in fundamental improvement or undervaluation.

QNC

Quantum eMotion Corp.

$2.21+$0.33

+17.4%

VNTG

Vantage CorpIndustrials

$0.76+$0.12

+17.4%

NYSE · Mkt cap $19 M

No news headlines were found in the last 48 hours for VNTAGE. The 17.39% gain is likely driven by technical factors, short covering, or untracked news sources.

The lack of any headlines in the Yahoo Finance RSS feed over the last two days makes it difficult to pinpoint a specific fundamental catalyst for this 17.39% jump in VNTAGE stock. At a price point of $0.76, this is a micro-cap or penny stock territory, where price movements are often more volatile and can be driven by factors other than traditional news coverage. Possible explanations include short squeeze dynamics if the stock had significant short interest, technical chart breakouts above resistance levels, options expiration activity, or news released through non-mainstream channels that did not appear in the headlines tracked. Without visible headlines or structural insight into the company's characteristics, we cannot determine the actual cause from the available evidence.

CNET

ChinaNet Online Holdings IncCommunication Services

$2.06+$0.29

+16.4%

NASDAQ · Mkt cap $5.4 M

No news headlines were available in the last 48 hours to explain the 16.38% jump in CNET stock, so the cause remains unclear without additional reporting.

The absence of any news headlines in the Yahoo Finance RSS feed over the past two days means we cannot tie this move to a specific corporate announcement, earnings surprise, regulatory action, or market event. For a small-cap Chinese internet stock like ChinaNet Online, a 16% single-day gain could theoretically reflect several categories of catalyst: a delayed earnings release or guidance update not yet widely distributed, a short squeeze or technical rebound after prior weakness, sector rotation into Chinese tech stocks, or purely retail trading activity on thin volume. Without evidence, all of these remain speculation. The company's low absolute price and NASDAQ listing make it susceptible to retail trading momentum as well as information asymmetry between Western and Chinese markets.

ONFO

Onfolio Holdings Inc. Common StCommunication Services

$1.06+$0.14

+15.8%

NASDAQ · Mkt cap $334 K

No news headlines are available for the last 48 hours, so the 15.82% intraday gain cannot be directly attributed to a specific company announcement or market event based on the provided evidence.

The absence of recent news makes it impossible to point to a concrete catalyst. Small-cap stocks like ONFO (trading at $1.06) are often subject to technical bounces, short covering, or reactions to delayed announcements that may not yet have propagated to major news feeds. Possible explanations include a positive earnings report, a business development announcement, insider buying, or relief from previous selling pressure. Alternatively, the move could be driven by social media activity, retail flow, or sector-wide momentum. Without access to real-time trading data, company filings, or intraday press releases, we cannot identify the actual trigger with confidence.

MAAS

Highest Performances Holdings Inc. - American Depository SharesFinancial Services

$17.91+$2.43

+15.7%

NASDAQ · Mkt cap $7.0 B

No news headlines were found in the last 48 hours, so the 15.7% gain on MAAS cannot be attributed to a specific announced catalyst. The move likely reflects technical buying, delayed news disclosure, or sector-wide momentum.

The absence of recent news headlines presents a clear limitation: we cannot identify a specific event such as earnings, FDA approval, partnership announcement, or guidance revision that would explain the sharp 15.7% jump. For a microcap or lower-volume stock like MAAS, price moves of this magnitude can be driven by several common factors absent from public headlines: technical breakouts above key resistance levels, short covering or gamma-driven demand, broader sector rotation into emerging markets or fintech (given the American Depository Share structure suggests a non-US company), retail trading momentum, or delayed/unindexed news that has not yet propagated to major financial RSS feeds. Without access to company filings, insider activity, or real-time order flow, pinpointing the precise catalyst remains speculative.

NAUT

Nautilus Biotechnology, Inc.Healthcare

$1.11+$0.15

+15.4%

NASDAQ · Mkt cap $114 M

No news headlines were available in the last 48 hours to explain Nautilus Biotechnology's 15.41% gain, suggesting the move may stem from technical trading activity, delayed news release, or market sentiment shift in the biotech sector.

Nautilus Biotechnology is a small-cap biotech company focused on protein analysis and characterization technology. With no recent news headlines provided, there is no factual basis to identify a specific corporate catalyst such as clinical trial results, partnership announcements, or regulatory developments. The 15.41% single-day gain on a stock trading at $1.11 is typical of low-priced biotech names that can experience elevated volatility from technical factors, short covering, or retail attention. Possible categories of catalyst include delayed news not yet reflected in wire feeds, commentary from analysts or social media, sector-wide biotech sentiment improvement, or internal corporate announcements not yet published broadly. Without confirmed headline evidence, attributing the move to any specific event would be speculative.

MOBQ

Mobiquity Technologies, Inc.Communication Services

$0.52+$0.07

+15.2%

NASDAQ · Mkt cap $19 M

No news headlines were found in the last 48 hours, so the 15.2% gain is unexplained by reported corporate events; the move is likely driven by technical trading, retail momentum, or unindexed rumors in microcap circles.

Mobiquity Technologies is a microcap stock trading at $0.52 with no recent news coverage captured in the headline feed. The absence of earnings, guidance, partnership announcements, or other corporate catalysts within the past two days makes it difficult to pinpoint a fundamental cause for the sharp 15.2% intraday jump. Microcap and penny stocks are particularly susceptible to technical bounces off support levels, short covering, or social media-driven retail attention that may not immediately appear in mainstream financial news wires. It is also possible that a material announcement was made outside the coverage window or via channels not captured by the Yahoo Finance RSS feed. Without additional context, the move should be treated as potentially volatile and speculative.

FLNA

Cassava Sciences, Inc.

$0.86+$0.11

+15.0%

DYAI

Dyadic International IncHealthcare

$0.47+$0.06

+14.8%

NASDAQ · Mkt cap $30 M

No news headlines were found in the last 48 hours, so the 14.83% gain on DYAI appears driven by factors other than published announcements, likely technical or microstructure-related activity.

The absence of recent news makes it difficult to pinpoint a specific catalyst for this move. DYAI is a small-cap biotech firm focused on enzyme engineering and fermentation technology, which historically tends to be sensitive to both positive clinical or commercial developments and technical trading activity. Given the stock's low absolute price of $0.47, it is susceptible to momentum trading, short covering, or algorithmic accumulation based on technical patterns or volume spikes. Biotech stocks in this market-cap range can also respond sharply to indirect signals such as sector rotation, insider activity, or pre-announced earnings or conference presentations that may not yet appear in headline aggregators. Without corroborating news, however, these remain speculative categories rather than confirmed drivers.

SFIX

Stitch Fix Inc

$2.47+$0.32

+14.6%

TANH

Tantech Holdings LtdConsumer Defensive

$16.99+$2.00

+14.3%

NASDAQ · Mkt cap $5.6 M

No news headlines were found in the last 48 hours, so the 14.28% gain likely reflects technical trading, a delayed market reaction to an earlier announcement, or speculation not yet covered by major news outlets.

The absence of recent headlines makes it difficult to pinpoint a specific catalyst for TANH's strong 14.28% rally on September 28, 2026. Without earnings reports, contract announcements, regulatory approvals, or guidance changes documented in the provided news feed, we cannot tie the move to a named event. Possible explanations fall into several categories: delayed market digestion of news released more than 48 hours prior, short covering or algorithmic buying in a thinly traded security, sector rotation into small-cap industrials or materials, or speculative interest not yet reflected in mainstream financial media. Tantech Holdings is a small-cap stock, which tend to experience larger percentage swings on lower volume and can be sensitive to rumors or social media activity that may not immediately appear in traditional news feeds.

TMCR

The Metals Royalty Company Inc.Basic Materials

$4.63+$0.57

+14.0%

NASDAQ · Mkt cap $396 M

No news headlines were found in the last 48 hours, so the 14% gain likely reflects either a delayed market reaction to an unindexed announcement, technical momentum, or sector-wide strength in metals and mining royalties.

The absence of recent news makes direct attribution impossible. The Metals Royalty Company is a royalty/streaming business that typically moves on commodity price shifts, exploration success at underlying assets, or company-specific developments like new deal announcements or portfolio updates. A 14% single-day jump without concurrent headline coverage suggests either a gap-up technical move, accumulation ahead of an expected announcement, sector tailwinds (precious metals or industrial metals strength), or a news event that has not yet been indexed by Yahoo Finance RSS feeds. Without visibility into the broader metals complex performance that day or company-specific catalysts, the precise driver remains unclear.

GPUS.PR.D

Hyperscale Data, Inc.

$19.05+$2.30

+13.7%

GPUS-D

Hyperscale Data, Inc.

$19.05+$2.30

+13.7%

REBN

Reborn Coffee, Inc.Consumer Cyclical

$1.41+$0.17

+13.7%

NASDAQ · Mkt cap $12 M

No news headlines were found in the last 48 hours, so the 13.71% gain likely reflects technical trading, delayed news dissemination, or market speculation in a small-cap coffee stock.

Reborn Coffee moved up sharply on September 28 with no corresponding news coverage in the Yahoo Finance RSS feed over the prior two days. This is a common pattern in lower-liquidity equities where price moves can outpace news distribution. Possible drivers include technical momentum or short-covering in a micro-cap name, delayed social media discussion that hasn't yet reached mainstream financial news wires, an after-hours announcement that will be formalized later, or simple intraday volatility amplification typical of stocks trading under $2. Without access to company filings, insider transactions, or social sentiment data from the snapshot date itself, attribution remains speculative.

FUSE

Fusion Acquisition CorpTechnology

$0.63+$0.08

+13.2%

NYSE · Mkt cap $24 M

Fusemachines announced accelerated AI Twin development through access to IBM Fusion Infrastructure via IBM Platinum Partner modulAIre, likely driving investor optimism about the company's technology roadmap and competitive positioning.

The headline describes a concrete operational development: Fusemachines has gained access to advanced AI infrastructure at nominal cost from IBM through a partnership arrangement. This type of announcement typically signals progress on a core product (AI Twin technology) and suggests validation through a major technology partner. The timing of the news release on the same day as the stock's 13.18% jump aligns with the move, though FUSE trades at a very low price ($0.63), which can amplify percentage moves on modest dollar volume. The news establishes a partnership benefit rather than a financial milestone or traditional catalyst, but it does address technology development velocity and cost reduction, both of which matter for SPAC-stage or early-stage tech companies seeking to demonstrate execution capability.

SCIIR

SC II Acquisition Corp. Rights

$0.17+$0.02

+13.1%

FBYD

Falcon's Beyond Global, Inc. - Class A Common StockIndustrials

$8.39+$0.93

+12.5%

NASDAQ · Mkt cap $387 M

No news headlines were found in the last 48 hours, so the 12.47% gain likely reflects either a delayed market reaction to an earlier announcement, technical trading activity, or untracked developments that moved the stock.

Falcon's Beyond Global operates in the experiential entertainment and immersive technology space, a sector that can be sensitive to momentum trading and sentiment shifts even without same-day news coverage. The absence of headlines in the Yahoo Finance RSS feed does not rule out developments reported through press releases, investor relations channels, earnings announcements, or conference activity that may not yet have propagated to the feed or that may have occurred just outside the 48-hour window. For a stock with moderate daily volume and a market cap in the lower-mid range, a 12% single-day move can also reflect short covering, institutional positioning changes, or rotation into the sector. Without access to the actual catalyst, it is reasonable to consider whether guidance was raised, a partnership was announced, or operational metrics improved, but these remain hypothetical.

KCAC.WT

$1.12+$0.12

+12.0%

AMC

AMC Entertainment Holdings IncCommunication Services

$3.28+$0.35

+11.9%

NYSE · Mkt cap $2.4 B

AMC surged 12% following announcement of a $3.97 billion refinancing package, including $2 billion in first-lien notes and an $850 million term loan, which extends the company's runway and outperformed peer reactions.

AMC announced a multibillion-dollar refinancing deal on September 21 that became public over the last 48 hours. The package comprises $2 billion of first-lien notes due 2031 and $850 million in first-lien term-loan syndication, providing material debt relief and liquidity extension. The stock's 12% jump reflects investor relief that the company secured meaningful refinancing without apparent distress pricing, especially given AMC's historical leverage concerns. Notably, peers Cinemark and IMAX saw minimal moves, suggesting the market views AMC's refinancing as company-specific good news rather than sector-wide tailwind. A concurrent report of record third-quarter domestic box office (over $3 billion) may have provided modest tailwind sentiment, though the refinancing announcement appears to be the primary catalyst. The gap between AMC's reaction and peer reactions indicates market confidence in the terms disclosed thus far, though full terms remain undisclosed as of the reporting window.

BUDA

Buda Juice, Inc.

$7.97+$0.82

+11.5%

SONM

Sonim Technologies IncTechnology

$4.35+$0.44

+11.1%

NASDAQ · Mkt cap $3.2 M

No news headlines were found in the last 48 hours for Sonim Technologies, so the 11.11% gain cannot be attributed to a specific reported event; the move likely reflects technical buying, delayed news dissemination, or sector-wide momentum.

Sonim Technologies is a rugged mobile device manufacturer serving enterprise and industrial markets. The stock jumped 11.11% to rank as the 40th biggest gainer on the day, yet no news headlines appear in the Yahoo Finance RSS feed for the prior 48 hours. This disconnect suggests either the catalyst was not yet picked up by major news aggregators, or the move was driven by non-fundamental factors. Sonim shares are relatively illiquid and thinly traded, making them susceptible to technical breakouts, short covering, or retail momentum plays. Alternatively, a corporate announcement, earnings release, or contract win may have occurred but not yet propagated through standard financial news channels. Without headline confirmation, attribution remains speculative.

INTJ

Intelligent Group LimitedIndustrials

$3.00+$0.30

+11.1%

NASDAQ · Mkt cap $5.0 M

No news headlines were found in the last 48 hours, so the 11% gain on INTJ lacks a clear public catalyst. The move may reflect technical trading, delayed news digestion, or market rumors not yet indexed by major news feeds.

Yahoo Finance returned zero headlines for Intelligent Group Limited in the 48 hours leading up to this 11% jump. Without a named earnings surprise, contract win, regulatory action, guidance change, or M&A announcement to anchor the move, the cause remains opaque. For a small-cap NASDAQ stock like INTJ ranking as the 41st biggest gainer of the day, rallies often stem from one of several generic sources: technical mean reversion or short covering if the stock had been oversold, a delayed pickup of news that broke after the 48-hour window closed, retail social-media attention, or unconfirmed market rumors. Without access to intraday volume data, insider trading filings, or real-time social sentiment, we cannot distinguish between these hypotheses.

BNKK

Bonk, Inc.

$1.87+$0.17

+11.0%

YDKG

AirNet Technology Inc.

$0.90+$0.10

+11.0%

MWYN

Marwynn Holdings, Inc. Common stockConsumer Cyclical

$1.08+$0.11

+11.0%

NASDAQ · Mkt cap $21 M

No news headlines were found in the last 48 hours, so the 10.96% gain cannot be attributed to a specific announced event; the move may reflect technical trading, a delayed news pickup, or market rumors not yet captured in major feeds.

The absence of recent news headlines makes it impossible to point to a concrete catalyst for MWYN's jump to 44 biggest gainer. For a micro-cap or penny stock like this one trading at $1.08, price moves of this magnitude can result from several common drivers including short covering, retail interest on social media or chat forums, technical breakouts above resistance, delayed news that hasn't yet propagated to major financial news aggregators, or sector-wide sentiment shifts. Without access to intraday volume data, level 2 quotes, or insider filing activity, attributing this move to any specific event would be speculation. The lack of headlines in the Yahoo Finance feed within 48 hours of the move suggests either the catalyst predates the snapshot or was too small to merit immediate coverage.

NYXH

Nyxoah S.A.Healthcare

$1.62+$0.16

+11.0%

NASDAQ · Mkt cap $165 M

Nyxoah appointed Liam Kelly as Chief Executive Officer on September 28, 2026, a leadership change announced the same day the stock jumped 10.96%, likely driving investor optimism about strengthened U.S. strategic focus.

The news headline confirms that Nyxoah announced the appointment of Liam Kelly as Chief Executive Officer on the same date as the stock's significant gain. The announcement explicitly mentions "further strengthening the Company's strategic U.S. presence and focus," which suggests the market may have viewed this leadership transition as a positive catalyst for business direction and execution. CEO appointments can drive investor confidence if the market perceives the incoming leader as capable of executing a valuable strategy or turning around underperformance. Without additional details about Kelly's background, the company's prior CEO situation, or market consensus on this specific hire, we cannot quantify how much of the 10.96% move is attributable to confidence in Kelly versus other factors such as short covering, technical positioning, or coincident sector momentum. The timing alignment is strong, but the depth of the bullish case remains limited by the brief announcement text provided.

TONX

Verb Technology Company, Inc.Financial Services

$3.97+$0.39

+10.9%

AGEN

Agenus IncHealthcare

$9.44+$0.90

+10.5%

NASDAQ · Mkt cap $329 M

No news headlines were found in the last 48 hours to explain AGEN's 10.47% gain, so the catalyst remains unclear. The jump likely stems from either delayed news coverage, technical trading, or a development not yet reflected in major financial news.

Agenus Inc is a clinical-stage immunotherapy company with a history of significant stock volatility tied to clinical trial data, partnership announcements, and financing news. The absence of any headlines in the past 48 hours despite a top-50 daily gain suggests either a lag in news aggregation, an after-hours or pre-market announcement that may not yet be fully indexed, or a technical/trading-driven move rather than fundamental news. Biotech stocks of this profile typically move sharply on trial readouts, FDA decisions, or therapeutic partnership deals. Without access to press releases, SEC filings, or real-time news outside the provided RSS feed, a specific catalyst cannot be identified from the evidence at hand.

BKHAR

Black Hawk Acquisition Corporation Rights

$1.70+$0.16

+10.4%

NASDAQ · Mkt cap $1.7 M

No news headlines were available in the last 48 hours, so the 10.39% gain likely reflects either technical trading activity, a delayed market reaction to earlier news, or typical volatility in SPAC rights instruments.

Black Hawk Acquisition Corporation Rights is a SPAC-related security, which tends to be volatile and sensitive to movements in the underlying SPAC or news about potential merger targets and deal timing. The absence of any news in the last 48 hours suggests the move was not driven by a named catalyst or announcement. Rights instruments can experience sharp price swings due to technical factors, changes in implied volatility around SPAC events, rotation flows, or market-wide sentiment shifts toward special purpose acquisition vehicles. Without headlines identifying a specific trigger, this appears to be either intra-market mechanics or a reaction to news published before the 48-hour window captured here.

ANNX

Annexon, Inc.Healthcare

$4.01+$0.38

+10.3%

GreenPower Motor Company Inc.

$0.64+$0.06

+10.3%

Biggest Losers

Mon, Sep 28, 2026 50

XHLD

TEN Holdings, Inc. Common StockCommunication Services

$0.98−$11.93

-92.4%

NASDAQ · Mkt cap $92 M

No news headlines were found in the last 48 hours to explain the 92.42% collapse in XHLD stock, making the root cause of this extreme decline impossible to determine from available evidence.

The complete absence of news in the prior 48 hours is striking given the magnitude of the move. A 92% single-day loss in a micro-cap stock like TEN Holdings typically correlates with a major negative catalyst: reverse split announcement, delisting warning, bankruptcy filing, massive dilution disclosure, or a major contract loss. Without headlines, we cannot confirm which category applies. Alternatively, the move could reflect a technical liquidity event in a low-volume security, a delayed market reaction to older news not captured in this 48-hour window, or trading halts that were subsequently lifted. Micro-cap stocks are also prone to rumors and speculative reversals that may not generate immediate press coverage. The absence of confirming headlines is the primary constraint here.

NCI

Navigant Consulting Inc

$2.41−$12.34

-84.2%

WINVR

WinVest Acquisition Corp.

$0.04−$0.07

-63.4%

NASDAQ

No news headlines were found in the last 48 hours to explain the 63% plunge in WINVR, making the cause unclear without access to broader market data or company-specific events released outside Yahoo Finance RSS coverage.

WinVest Acquisition Corp. is a SPAC, a structure inherently sensitive to shifts in investor sentiment, redemption pressures, and deal prospects. The 63% single-day drop is severe and suggests either a major negative announcement (potential deal termination, failed merger, shareholder vote loss, or material adverse event) or a sudden shift in SPAC market conditions, but without news coverage in the provided timeframe there is no way to confirm the specific trigger. SPACs with minimal liquidity can also experience sharp moves on light volume. The absence of headlines does not rule out an event; it may reflect a delay in news dissemination, a private communication to shareholders, or coverage gaps in the RSS feed. Inference: Likely categories are deal-related deterioration, redemption dynamics, or a broader SPAC market selloff, but this remains speculative without corroborating evidence.

ATHHF

Aether Catalyst Solutions Inc.Consumer Cyclical

$0.00−$0.00

-52.3%

NCT

Intercont (Cayman) Limited Ordinary sharesIndustrials

$2.85−$1.96

-44.3%

NASDAQ · Mkt cap $38 M

NCT fell 44.34% on September 28 with no news headlines identified in the last 48 hours, making the precise cause unclear but suggesting either delayed market reaction to untracked news, technical selling, or a significant corporate event not yet indexed by Yahoo Finance.

No recent news headlines were returned for NCT in the 48 hours surrounding this sharp 44% single-day drop, which limits our ability to pinpoint a specific catalyst. For a company trading at $2.85 with a relatively low price point, several common triggers could apply: earnings disappointment or surprise guidance cut (typical for major one-day declines), material news about business operations or financing, insider transactions, analyst downgrades not yet reflected in headline feeds, or sector-wide pressure. The magnitude of the loss and its ranking as the fifth-largest loser suggests something material rather than pure technical selling, but without confirming headlines, the exact nature remains unknown. The absence of tracked news could indicate the catalyst originated outside major wire services or that headlines are delayed in propagating to secondary feeds.

GYGY

Game Your Game, Inc.Technology

$0.88−$0.62

-41.8%

NASDAQ · Mkt cap $25 M

GYGY surged 90% in premarket on announcement of its GameGolf KZN AI platform launch, but closed down 42%, suggesting either profit-taking, a subsequent negative catalyst, or market disappointment after the initial hype dissipated throughout the trading day.

The headline from Monday morning reports a significant premarket rally of over 90% following the company's announcement of full commercial availability of its next-generation GameGolf KZN AI platform. This is a concrete positive catalyst that clearly triggered the initial surge. However, the stock closed down 41.76%, indicating a dramatic reversal. This pattern suggests one of three scenarios: aggressive profit-taking after the morning spike, a negative development or clarification that emerged later in the trading session that offset the enthusiasm, or a sell-the-news dynamic where market participants decided the actual product announcement was less impressive than the premarket sentiment implied. Without additional intraday headlines or company statements after the initial announcement, the precise reason for the reversal cannot be determined with certainty.

GETY

Getty Images Holdings, Inc.Communication Services

$0.08−$0.06

-40.6%

NYSE · Mkt cap $111 M

Getty Images plummeted 40.62% after Bloomberg reported the company is in confidential discussions with lenders about rescue financing, likely including a debtor-in-possession loan, signaling severe financial distress.

The headline establishes that Getty Images is actively negotiating emergency financing with lenders, a development that typically signals a company is near insolvency or restructuring. A debtor-in-possession loan is a financing tool commonly used by companies in or approaching bankruptcy proceedings, giving lenders priority repayment and indicating creditors have lost confidence in the company's ability to service existing debt from operations. The fact that this discussion is confidential but leaked to Bloomberg suggests either deliberate signaling by management or uncontrolled information flow, both of which erode investor confidence. The 40% single-day drop reflects the market's interpretation that existing shareholders face substantial dilution risk or total loss in a restructuring scenario. The second headline about consumer stocks being mixed is generic sector commentary unrelated to Getty's company-specific crisis.

HEPA

Hepion Pharmaceuticals IncHealthcare

$0.06−$0.04

-37.9%

NASDAQ · Mkt cap $5.5 M

No news headlines were found in the last 48 hours, so the 37.87% decline cannot be attributed to a specific announced event. The drop likely reflects either delayed reaction to older news, technical selling pressure, or undisclosed company developments.

The absence of recent headlines makes it impossible to pinpoint the exact catalyst for HEPA's steep single-day decline. Hepion Pharmaceuticals is a clinical-stage biopharmaceutical company with a history of significant volatility tied to clinical trial results, regulatory decisions, and financing activities. For a micro-cap biotech trading at $0.06, moves of this magnitude often stem from clinical trial data releases, FDA correspondence, capital raise announcements, or changes in pipeline status. The stock's ranking as the eighth biggest loser suggests broad selling pressure rather than isolated institutional exits. Without news from the past 48 hours, the decline could reflect a delayed market reaction to information released earlier, technical stop-loss selling following a previous breakdown, or unannounced company developments that have not yet appeared in public headlines.

MSGY

Masonglory LimitedIndustrials

$3.15−$2.21

-37.7%

NASDAQ · Mkt cap $5.8 M

Masonglory announced a $1 million private placement to fund acquisition of stake in a German company, which likely triggered shareholder dilution concerns and sparked the 37.71% sell-off.

The headline confirms a private placement announcement on September 28, 2026, the same day as the massive price drop. Private placements typically dilute existing shareholders because new equity is issued at a discount to current market price, reducing ownership percentage and earnings per share for current holders. The relatively modest size of the offering ($1 million) combined with the severe magnitude of the decline (37.71%) suggests either significant pre-existing weakness in investor sentiment toward the company, concern about the acquisition target's quality or the dilution math, or that the market had already priced in negative expectations and this announcement simply confirmed them. The company operates as a wet trades subcontractor in Hong Kong and appears to be diversifying into German holdings, which may raise questions about strategic direction. However, the headline is truncated and lacks specifics on valuation, discount pricing, or market reaction context that would fully explain the severity of the move.

WYTC

WYTEC INTERNATIONAL INC

$0.57−$0.33

-36.7%

NASDAQ

No news headlines were found in the last 48 hours to explain WYTEC International's 36.66% stock price decline, suggesting the move was driven by factors outside major press coverage such as insider activity, technical selling, or undisclosed company developments.

The sharp 36.66% drop in WYTEC International with zero news headlines in the prior two days indicates the catalyst was not a major announced event. For a micro-cap stock trading at $0.57, plausible but unconfirmed causes include insider selling or lockup expiration, a missed earnings or guidance update not yet widely reported, short-seller activity or negative research report, technical breakdown from technical support levels, or delayed disclosure of company-specific problems. Without access to SEC filings, insider transaction reports, or company announcements filed directly, the specific trigger remains speculative. Stocks at this price point and market cap often move on thin volume and modest share sales.

JONER

Jones Ventures INTL Acquisition1 Corp

$0.10−$0.05

-33.3%

GENVR

Gen Digital Inc. Contingent Value Rights

$0.74−$0.36

-32.7%

NASDAQ

A takeover report showing GoDaddy as the potential acquirer triggered a sharp sell-off in GENVR (Gen Digital CVR), signaling market skepticism that Gen Digital shareholders will realize value from the deal structure.

The headline explicitly links GENVR's 32.73% decline to a GoDaddy takeover report. The article's key insight is that when a would-be buyer's stock falls far harder than the target's rises, it signals market doubts about deal economics. GENVR represents contingent value rights tied to Gen Digital, meaning its payoff depends on the acquisition completing and delivering the promised consideration. A sharp drop in the buyer's stock often presages either deal risk (financing concerns, regulatory obstacles, or deal termination risk) or a realization that the buyer is overpaying, which could translate into lower final payouts to CVR holders. The market is implying that GoDaddy shareholders see limited upside, which undermines confidence in the deal's structure and timing for GENVR holders.

ITG

ITG, Inc.Industrials

$7.07−$3.31

-31.6%

NASDAQ · Mkt cap $1.6 B

ITG dropped 31.6% on September 28 with no news headlines available in the prior 48 hours, making the specific cause unclear; the move likely reflects a material event, earnings miss, guidance cut, or other market-moving disclosure either released outside the news feed window or not yet widely rep…

No relevant news headlines were found in the last 48 hours, yet ITG suffered a severe one-day loss ranking it among the day's top 13 losers. This magnitude of decline typically requires a concrete catalyst such as earnings disappointment, dividend suspension, analyst downgrade, regulatory action, or strategic misstep. The absence of headlines in the capture window does not mean no news occurred; the announcement may have been released earlier in the day, on a wire service not indexed by Yahoo Finance's RSS, or as a press release without immediate news media pickup. For a smaller-cap equity trading on NASDAQ, liquidity constraints or forced selling could amplify intraday moves, but a 31.6% drop usually indicates fundamental news rather than pure technical pressure. Without access to the actual announcement, the most probable categories remain quarterly earnings results, guidance revision, or material business development.

SHFS

SHF Holdings, Inc.Financial Services

$0.11−$0.05

-30.6%

ACET

Adicet Bio, Inc.

$6.26−$2.75

-30.5%

CSAI

Cloudastructure, Inc. Class A Common StockTechnology

$2.50−$1.09

-30.4%

NASDAQ · Mkt cap $4.5 M

No news headlines were found in the last 48 hours for Cloudastructure, so the 30% drop cannot be directly attributed to a disclosed event; the decline likely stems from broad market conditions, technical selling, or undisclosed information.

The absence of recent news headlines in the Yahoo Finance RSS feed for the past 48 hours means we cannot point to a specific corporate announcement, earnings surprise, regulatory action, or deal-related catalyst. A 30% single-day drop for a stock trading at $2.50 is substantial. For a company at this price level and market position, typical catalysts that drive large moves include missed earnings or negative guidance, significant insider selling or lock-up expirations, debt covenant violations, customer losses, bankruptcy concerns, or short squeeze reversals. It is also possible the decline reflects a delayed market reaction to news released slightly earlier, or reflects broader selloff pressure in a sector or broader market decline. Without access to news, trading volume data, or the company's recent financial position, we cannot distinguish between these scenarios.

LABT

Lakewood-Amedex Biotherapeutics Inc.Healthcare

$1.13−$0.50

-30.3%

NASDAQ · Mkt cap $3.8 M

Lakewood-Amedex announced positive Phase 2a trial initiation and preclinical data on the same day, yet the stock fell 30%, suggesting market skepticism about clinical/commercial viability or potential dilution concerns despite the positive milestone.

The headlines document three concurrent announcements on September 28: dosing of the first patient in Phase 2a for Nu-3, positive preclinical antimicrobial data, and upcoming Phase 2a topline results. These are typically viewed as positive clinical catalysts by biotech investors. However, the 30% intraday decline contradicts the expected positive reaction to trial initiation and efficacy data. This disconnect suggests either: (1) the market had already priced in these milestones and the confirmation disappointed relative to expectations, (2) the company made concurrent announcements of financing or dilution not mentioned in the provided headlines, or (3) existing short positioning or technical selling pressure overwhelmed the fundamental positive news. Without access to detailed press releases, SEC filings, or earnings call transcripts from today, the specific negative catalyst remains unclear.

FIXX

Homology Medicines Inc

$9.23−$3.79

-29.1%

XXII

22nd Century Group IncConsumer Defensive

$0.94−$0.38

-28.8%

NASDAQ · Mkt cap $1.4 M

XXII fell 28.84% despite positive news about its reduced-nicotine tobacco platform being positioned to support France's regulatory initiative, suggesting the market rejected the announcement or broader sector/company-specific headwinds overwhelmed the headline.

The single headline from 2026-09-28 is actually favorable on its surface: an independent French health agency (ANSES) has recommended nicotine limits for combustible tobacco, and 22nd Century Group's reduced-nicotine platform is positioned to address this regulatory shift. This would normally be viewed as a tailwind for the company's business model. However, the stock collapsed 28.84% on the same day the news broke, which suggests either the market interpretation differed sharply from the headline's framing, investors doubted the company's ability to capitalize on the opportunity, concerns about execution or commercialization timelines, or more likely, an unrelated negative catalyst (earnings miss, insider selling, broader biotech/tobacco sector weakness, short covering reversal) occurred that the provided headlines do not capture. The 19th biggest loser ranking on a single day points to material adverse news beyond this regulatory development.

NRSN

NeuroSense Therapeutics Ltd.Healthcare

$5.10−$2.00

-28.2%

NASDAQ · Mkt cap $14 M

NeuroSense fell 28% on September 28, but the only news provided is a routine conference participation announcement from the same day, which does not explain a drop of this magnitude. The cause remains unclear from available evidence.

The headline provided is a standard corporate disclosure about the Chief Financial Officer's participation in the ROTH Healthcare Opportunities Conference—a typical non-material event that does not typically drive large single-day declines. The timing and content of this announcement do not align with a 28% stock drop. For a late-stage clinical biotech company, common catalysts for sharp declines include negative clinical trial data, regulatory setbacks (FDA feedback or rejection), capital raises at depressed valuations, insider selling, or sector-wide biotech selloffs. Without additional headlines beyond the conference participation notice, we cannot establish a concrete cause from news alone.

AIFU

Fanhua Inc.Financial Services

$8.90−$3.45

-28.0%

NASDAQ · Mkt cap $74 M

No news headlines were found in the last 48 hours, so the 27.96% drop cannot be attributed to a specific announced event. The decline likely reflects either delayed market reaction to an earlier announcement, technical selling pressure, or broader sector headwinds affecting education or financial…

The absence of recent news makes it impossible to pinpoint a single catalyst for AIFU's sharp 27.96% decline. Fanhua Inc. operates in the Chinese education and financial services sector, which can be sensitive to regulatory changes, macroeconomic shifts in China, or shifts in investor sentiment toward the sector. Without headlines from the last 48 hours, the decline could stem from several plausible but unconfirmed sources: a delayed market reaction to an announcement made earlier than the news window captured, technical selling after the stock reached a local peak, sector-wide weakness in China-focused equities, or adverse comments from analysts or institutional investors that spread through trading channels rather than formal press releases. The ranking as the 21st biggest loser suggests broad market weakness rather than a company-specific positive catalyst that offset negative news.

BNCWW

CEA Industries Inc. WarrantIndustrials

$0.01−$0.00

-27.9%

NASDAQ

No news headlines appeared in the last 48 hours, so the 27.86% drop cannot be attributed to a specific disclosed catalyst; warrant price volatility is common and can reflect underlying stock weakness, time decay, or reduced implied volatility.

The absence of any news in the provided headline feed means no specific event (earnings, clinical results, contract win, guidance, or corporate action) can be identified as the direct cause of this warrant's sharp decline. BNCWW is a warrant on CEA Industries, a security class known for high sensitivity to leverage and time decay. Warrant prices erode as expiration approaches, especially if the underlying stock weakens. The drop could reflect a decline in the underlying CEA stock, a contraction in implied volatility, passage of time, or reduced retail interest in the warrant itself. Without access to CEA's own stock price action or warrant-specific data (implied vol, days to expiration, moneyness), any explanation remains speculative. It is also possible that news moved the underlying stock before the headline service captured it, or that a small-cap warrant experienced a quiet technical liquidation.

TGL

Treasure Global Inc.Technology

$1.48−$0.56

-26.7%

NASDAQ · Mkt cap $5.7 M

Treasure Global announced a US$38 million acquisition of a 51% stake in a smart water metering company on the day of the 26.67% stock drop, suggesting the market viewed the deal unfavorably, possibly due to valuation concerns, dilution, or strategic doubts about the utility infrastructure pivot.

The timing of the acquisition announcement on the same day as the massive sell-off creates a direct connection. However, the headline itself does not reveal the deal's terms from the market's perspective—whether the purchase price was seen as overpaying, whether financing details raised concerns about shareholder dilution, or whether investors questioned the strategic fit of expanding into smart utility infrastructure. The lack of detail on whether this was an all-cash deal, stock-based, or mixed financing is notable; an equity raise could trigger immediate selling. The 51% controlling stake structure and the company's shift into AI-enabled infrastructure are factual, but market reaction to such pivots varies widely. Without access to analyst commentary, the full press release, or trading context, the precise reason for rejection cannot be definitively established, though the temporal correlation strongly suggests this deal announcement is the primary catalyst.

GCDT

Green Circle Decarbonize Technology LimitedIndustrials

$0.48−$0.17

-26.1%

NYSE · Mkt cap $5.2 M

No news headlines were reported in the last 48 hours for GCDT, so the 26.1% drop cannot be directly attributed to a disclosed catalyst. The decline likely reflects technical selling, market-wide pressure, or an undisclosed company event not yet picked up by major news outlets.

The absence of any news in the 48-hour window preceding this significant 26% single-day loss makes direct attribution impossible. For a small-cap green technology stock trading at $0.48, possible causes include technical breakdown below support levels triggering algorithmic selling, broader market sector rotation away from ESG or clean energy plays, investor disappointment with unannounced operational developments or delays, short-seller activity, or delayed reporting of company-specific news not yet reflected in major financial news feeds. Given GCDT's microcap profile and speculative nature, intraday volatility and gap moves are not uncommon even without catalyst news. Without headlines or structural insight into this specific security, the root cause remains unclear.

DCOY

Decoy Therapeutics IncHealthcare

$2.32−$0.76

-24.7%

CUEN

Cuentas Inc.Technology

$0.49−$0.16

-24.4%

NASDAQ · Mkt cap $5.4 M

No news headlines were found in the last 48 hours for CUEN, so the cause of the 24% single-day drop cannot be determined from available reporting. The decline likely stems from a market-moving event not yet captured in major financial news feeds.

With no recent headlines available to explain a 24% intraday decline, we cannot point to a specific corporate event, earnings miss, regulatory action, or guidance change. For a micro-cap stock trading at $0.49, common catalysts for sharp single-day drops include delayed financial reporting, adverse trading halts, insider selling disclosures, failed clinical trials or regulatory setbacks if biotech-related, contract cancellations, or major shareholder liquidations. It is also possible the move reflects accumulated selling pressure from technical or sentiment factors, a rumor not yet in mainstream financial media, or a delayed market reaction to news released before the 48-hour window. Without access to the company's filings, conference calls, or real-time trading data, the specific trigger remains unknown.

TREO

Tactical Resources Corp.

$2.80−$0.86

-24.0%

TWG

Top Wealth Group Holding Limited Ordinary SharesConsumer Defensive

$0.13−$0.04

-23.8%

NASDAQ · Mkt cap $22 M

No headlines were reported in the last 48 hours, making the 23.79% drop unexplained by publicly disclosed news. The decline likely stems from technical selling, broader market weakness, or undisclosed company developments.

Without any news headlines provided for the past 48 hours, there is no direct explanation for the sharp 23.79% decline in TWG stock. The lack of reported information creates an information vacuum. For a microcap stock trading at $0.13, typical drivers of large single-day drops include technical capitulation or stop-loss selling triggered by volume or price patterns, sudden shifts in investor sentiment toward the sector or the company's business model, unconfirmed rumors or chatter on retail forums, delayed announcements of adverse earnings or guidance, insider transactions, regulatory concerns, or shifts in institutional positioning. Without access to intraday trading patterns, company filings, or substantive news, we cannot pinpoint the specific catalyst.

TDTH

Trident Digital Tech Holdings Ltd American Depository SharesTechnology

$1.12−$0.34

-23.3%

NASDAQ · Mkt cap $2.3 B

No news headlines were found in the last 48 hours, so the cause of the 23.29% drop cannot be determined from available reporting. The decline may reflect earnings, a corporate action, market technicals, or an unindexed rumor.

Yahoo Finance returned no headlines for TDTH in the past two days despite a significant single-day loss ranking it among the 29 biggest losers on NASDAQ. This absence of reported news is notable and suggests several possibilities. First, the catalyst may not yet be widely covered by major news outlets, which happens occasionally with smaller-cap or thinly traded stocks. Second, the move could be driven by technical factors, sector rotation, or algorithmic trading rather than a discrete corporate event. Third, there may be a company announcement, earnings release, or regulatory filing that has not yet propagated to the RSS feed being monitored. Without access to the company's investor relations page, SEC filings, or trading data, we cannot determine whether this is company-specific or market-driven.

HUBC

Hub Cyber Security Ltd. - Ordinary SharesTechnology

$1.48−$0.42

-21.9%

NASDAQ · Mkt cap $23 M

No news headlines were available in the last 48 hours to explain HUBC's 21.9% decline, so the catalyst remains unknown; this magnitude of drop often reflects earnings misses, insider selling, or sector rotation in smaller-cap cybersecurity stocks.

The absence of any headlines in the Yahoo Finance RSS feed for the past 48 hours means we cannot identify a specific announced catalyst for this sharp decline. Hub Cyber Security is a smaller-cap NASDAQ stock, and such securities can experience large single-day moves on volume spikes, technical breaks, or delayed news absorption that may not immediately appear in mainstream feeds. Possible categories of cause include quarterly earnings disappointment (if reported outside standard hours), a negative analyst downgrade, broader sector rotation away from cybersecurity, insider selling activity, or a delayed disclosure that the market is pricing in ahead of formal announcement. Without access to real-time SEC filings, earnings calendars, or the company's investor relations channels, we cannot pinpoint which of these is responsible.

COPL.WT

Copley Acquisition Corp WT

$0.03−$0.01

-21.8%

OCUL

Ocular Therapeutix IncHealthcare

$7.66−$2.01

-20.8%

NASDAQ · Mkt cap $2.4 B

OCUL dropped 20.76% after competitors KOD and FDMT announced clinical updates on wet AMD treatments, likely intensifying competitive pressure in the space and raising concerns about OCUL's market position in that therapeutic area.

The headline directly attributes the sharp selloff to clinical announcements from rival companies developing wet age-related macular degeneration (AMD) drugs. In biotech and ophthalmology, competitive clinical data often triggers re-rating of peers in the same indication, particularly if the competitor's data appears superior or suggests a crowded field. OCUL appears to have a wet AMD asset or pipeline focus, making it directly exposed to this competitive dynamic. The magnitude of the drop (21%) suggests the market viewed these competitor updates as material enough to shift investment thesis or de-risk the competitive outlook for OCUL's program. Without details on whether OCUL itself has a wet AMD asset or its stage relative to KOD and FDMT, the exact mechanism of impact is not fully clear, but competitive clinical readouts regularly trigger repricing in ophthalmology and specialty biotech.

HOST

Host Digital Inc. Class A

$4.91−$1.26

-20.4%

JACS.RI

Jackson Acquisition Company II

$0.04−$0.01

-20.0%

WTER

Alkaline Water Co Inc-TheConsumer Defensive

$0.02−$0.00

-20.0%

NASDAQ · Mkt cap $1.1 M

No news headlines were found in the last 48 hours to explain the 20% drop, so the cause remains unclear, though penny stocks like WTER are prone to sharp moves on thin trading volume and lack of liquidity.

The absence of any recent news headlines is notable for a stock experiencing a significant single-day decline of 20%. Alkaline Water Company is a micro-cap penny stock trading at $0.02, a category of security that typically exhibits high volatility independent of fundamental catalysts. Possible explanations for the move include technical selling triggered by breaking a support level, thin liquidity amplifying routine bid-ask spread widening, a delayed announcement not yet reflected in the Yahoo Finance feed, or broad market weakness in small-cap equities. Without access to intraday volume data, trading halts, or insider transaction filings, it is not possible to definitively identify the trigger. Penny stocks frequently experience sharp single-day swings driven by factors such as option expiration, margin calls, or algorithmic trading activity rather than material business news.

ONEN

Hennessy Capital Investment Corp. VII

$2.14−$0.53

-19.9%

USDEW

StablecoinX Inc. Warrants

$4.83−$1.19

-19.8%

MNOV

MediciNova Inc

$2.07−$0.51

-19.8%

JAGX

Jaguar Health IncHealthcare

$5.99−$1.42

-19.7%

NASDAQ · Mkt cap $4.5 M

No headlines were available in the last 48 hours to explain Jaguar Health's 19.67% decline, so the cause remains unknown and could stem from market technicals, delayed news digestion, or an untracked announcement.

The absence of recent headlines in the last 48 hours prevents us from identifying a concrete catalyst for JAGX's sharp 19.67% decline. Given that Jaguar Health is a small-cap biopharmaceutical company with a limited float, the stock may be subject to high volatility driven by factors such as clinical trial data releases, regulatory decisions on its marketed products, changes in analyst coverage or institutional positioning, or broader biotech sector weakness. Without access to news beyond the 48-hour window, we cannot rule out that a material announcement or decision occurred just outside our search window, or that the move reflects technical selling pressure on a thinly traded security.

FCRS.WT

FutureCrest Acquisition Corp. WT

$0.51−$0.12

-19.6%

KITT

Nauticus Robotics, Inc.

$1.82−$0.43

-19.4%

CYPH

Cypherpunk Technologies Inc.Financial Services

$3.31−$0.79

-19.2%

NASDAQ · Mkt cap $115 M

No news headlines were found in the last 48 hours, so the 19% drop cannot be attributed to any identified catalyst. The decline may reflect technical selling, delayed market reaction to an older event, or sector-wide pressure.

The absence of recent news makes it difficult to pinpoint a specific cause for CYPH's sharp 19.17% decline. Cypherpunk Technologies is a small-cap equity security, and securities in this category are prone to volatility driven by factors beyond major headline announcements. Possible explanations include profit-taking after a prior run-up, broader cryptocurrency or technology sector weakness affecting investor sentiment toward blockchain-related firms, heavy short-selling activity, or delayed market reaction to company developments announced more than 48 hours ago. Without access to intraday trading data, social media discussion, or older press releases, attributing the move to a specific event remains speculative. Retail and institutional holder redemptions or margin calls can also trigger sharp moves in lower-liquidity names.

IMDX

Insight Molecular Diagnostics Inc.Healthcare

$3.18−$0.75

-19.1%

NASDAQ · Mkt cap $143 M

No news headlines were published in the last 48 hours for IMDX, so the 19% drop cannot be attributed to a specific announced event; the decline likely reflects broader market pressure, earnings concerns, or undisclosed company developments.

The absence of any Yahoo Finance headlines in the last 48 hours means this move cannot be tied to a specific catalyst that made it into major news feeds. For a diagnostic stock like Insight Molecular Diagnostics, typical drivers of sharp single-day declines include missed earnings or revenue guidance, FDA regulatory setbacks, loss of a major contract or partnership, competitive pressure announcements, or insider selling. The stock ranks as the 43rd biggest loser today, suggesting the decline is real and substantial rather than a technical blip. Without news coverage, the cause could be a delayed market reaction to an older announcement, a press release that bypassed major news aggregators, broader sector rotation out of diagnostics, or negative sentiment from an earnings call or investor event that occurred outside the news cycle captured here. The magnitude of the drop warrants investigation into company filings and social media for context the RSS feed did not capture.

MGRX

Mangoceuticals, Inc. - Common StockHealthcare

$0.38−$0.09

-19.0%

NASDAQ · Mkt cap $7.2 M

No news headlines were found in the last 48 hours, so the 19% drop cannot be directly attributed to a reported catalyst. For a micro-cap biotech stock like MGRX, the decline likely reflects sector weakness, profit-taking, or deteriorating sentiment in early-stage life sciences companies.

The absence of any recent news makes it impossible to point to a specific disclosed event driving the 18.99% decline. Mangoceuticals appears to be a small-cap biotech or nutraceutical company with limited liquidity and analyst coverage, which makes price movements volatile and susceptible to technical factors. The loss could stem from several non-news sources common to this stock category: broad biotech sector pullback, expired or lapsed investor interest, routine rebalancing by holders, or negative sentiment toward early-stage drug or supplement development companies. Without a concrete headline or filing, the drop must be classified as driven by structural market dynamics rather than company-specific news.

AUID

Ipsidy Inc.Technology

$0.38−$0.09

-18.7%

NASDAQ · Mkt cap $7.0 M

No news headlines appeared in the last 48 hours for AUID, so the 18.71% drop on September 28th cannot be directly attributed to a disclosed event. The decline is likely driven by technical selling, market-wide pressure, or undisclosed company developments.

With no headlines provided in the recent news feed, there is no disclosed catalyst for today's sharp decline. Ipsidy is a smaller-cap security focused on identity verification and cybersecurity solutions, which can be subject to heightened volatility and technical trading patterns. For microcap stocks trading in the sub-dollar range, daily moves of this magnitude often reflect algorithmic selling, portfolio rebalancing, short-covering reversals, or broader sector rotation rather than company-specific news. Alternatively, there could be an unannounced development—such as an insider transaction, delayed SEC filing, or earnings preannouncement—that has not yet propagated to major financial news feeds. Without headlines or official disclosures to reference, the true cause remains speculative.

MDB

MongoDB IncTechnology

$334.60−$75.75

-18.5%

NASDAQ · Mkt cap $34 B

MongoDB CEO Chirantan Desai resigned immediately to become Meta's Chief Enterprise Platform Officer, triggering an 18.5% stock plunge as investors worry about leadership continuity and competitive threats from Meta's new enterprise push.

Multiple headlines confirm that MongoDB's President and CEO Chirantan Desai departed effective immediately to join Meta in a senior enterprise role. This is a material leadership vacuum at a critical time, particularly concerning for a software infrastructure company where executive stability matters to enterprise customers and investor confidence. The news also signals Meta's aggressive entry into enterprise software, potentially positioning it as a competitive threat to MongoDB's core business. While one headline notes that founder Dev Ittycheria may return and that the company is searching for a permanent CEO, the market's immediate reaction reflects concern about execution risk, customer retention, and strategic direction during the transition. The 18% decline is proportionate to this type of sudden C-suite departure at a mid-cap software firm.

APACR

StoneBridge Acquisition II Corporation Rights

$0.09−$0.02

-18.1%

LESL

Leslie''s IncConsumer Cyclical

$0.24−$0.05

-18.0%

NASDAQ · Mkt cap $6.1 M

No news headlines were found in the last 48 hours, so the 18% decline cannot be directly attributed to a reported catalyst. The drop likely reflects broader market pressure, technical selling, or undisclosed company developments.

Leslie's Inc, a pool supplies and maintenance retailer, experienced an 18% single-day decline with no corresponding news in the provided 48-hour window. This gap between price action and available information makes causal attribution difficult. For a discretionary consumer goods stock like this, typical catalysts include quarterly earnings misses, margin compression, inventory warnings, or broader sector weakness in leisure spending. The stock's current price of $0.24 suggests it may already have faced significant challenges, possibly including prior losses or restructuring. Without headlines, the decline could reflect technical selling pressure, short covering reversal, delayed market reaction to earlier news, or company-specific developments not yet publicly reported or picked up by the news feed.

PPCB

Propanc Biopharma, Inc.Healthcare

$0.53−$0.12

-18.0%

NASDAQ · Mkt cap $2.6 M

No headlines were available in the last 48 hours, so the cause of the 17.99% drop cannot be directly established from news. The decline may reflect sector weakness, clinical setbacks, capital raises, or broader biotech volatility affecting micro-cap stocks.

Propanc Biopharma is a pre-revenue biotech company with a small market capitalization, making it highly sensitive to clinical updates, funding announcements, and sector sentiment. The absence of news in the last 48 hours suggests the decline was not driven by a major press release or earnings report. For this category of stock, losses of this magnitude typically stem from one of several causes: delayed or negative clinical trial results announced via SEC filing rather than press release, capital dilution from an unannounced or just-announced equity offering, loss of a partnership or funding commitment, insider selling signaling concern, or broad sector downturn in micro-cap biotech. Without access to SEC filings, insider transaction logs, or detailed price action context, the specific trigger cannot be determined. The stock's position as the 49th biggest loser suggests this was not an isolated or technical move but rather part of a broader market trend affecting small-cap equities that day.

NCPL

Netcapital Inc.Financial Services

$1.11−$0.24

-17.9%

NASDAQ · Mkt cap $1.8 M

No news headlines appeared in the last 48 hours for NCPL, so the 17.88% drop cannot be attributed to a specific announced catalyst. The decline likely stems from technical selling, sector headwinds, or undisclosed market factors affecting micro-cap stocks.

The absence of recent news makes it difficult to pinpoint the exact cause of Netcapital's sharp 17.88% decline. Netcapital is a micro-cap fintech and investment platform company, and stocks in this category are often highly sensitive to liquidity conditions, retail sentiment, and broad market moves in growth or technology sectors. The drop could reflect sector-wide pressure, portfolio rebalancing, or technical breakdown from resistance levels. Without accompanying headlines, it is equally possible that news of regulatory concerns, delayed filings, or insider transactions were disseminated through channels not captured in the RSS feed provided. A single large sell order or short interest activity could also trigger such a move in lower-liquidity securities.